|
|
Research strengths
Examples of Currently
Funded Vaccine Projects:
Principal Investigator |
Project Title |
Anticipated |
Bennett,Nancy M |
Surveillance for SARS and Severe
Pneumonia Syndrome in the EIP Network |
556,012 |
Dewhurst,Stephen |
Bacteriophage Gene Transfer for
HIV Vaccine Delivery |
468,000 |
Fowell, Deborah J |
The Role of Itk in Th Differentiation |
1,600,193 |
Frelinger,John G |
Large-scale Antibody and T Cell
Epitope Discover Program |
1,843,798 |
Gigliotti,Francis |
Lung Damage from P. carinii: Pathogenesis
and Prevention |
7,450,547 |
Hay,Christine M |
A DB, Randomized, Controlled Phase
III Study to Assess the Prophylactic
Efficacy & Safety of gD-Alum/MPL Vaccine in the Prevention of Genital
Herpes… |
1,023,752 |
Iglewski, Barbara H |
Clinical Vaccine Trials Testing
- Group I and Group II |
4,368,794 |
Iglewski, Barbara H |
Molecular Pathogenesis of Bacteria
and Viruses |
1,182,467 |
Jin,Xia |
Standardizing Measurements of
HIV-specific CD8+ T Cells |
1,081,193 |
Keefer,Michael C |
HSV-1 Amplicon Vectors for HIV
Vaccine Delivery |
11,810,305 |
Livingstone, Alexandra Mary |
CD8+ T Cell Memory Primed by Dendritic
Cells |
1,260,667 |
Miller,James F |
Multiple Pathways of CD28 Costimulation |
1,053,000 |
Mosmann, Tim R |
Differentiation & Function,
Precursor & Effector T Cells |
1,776,431 |
Mosmann, Tim R |
Bi-directional Interactions Between
Immunity & Pregnancy |
787,500 |
Mosmann, Tim R |
RSV Specific Responses in Viral
Elimination & Disease |
472,500 |
Mosmann, Tim R |
Human Immunology Center at the
University of Rochester |
3,783,804 |
Moynihan,Jan A |
Immunoregulation by Endogenous
Opioids |
1,311,593 |
Mullen,Craig A |
Leukemia Immunotherapy After Allogeneic
Transplant |
1,438,794 |
Pavelka, Martin |
Development of Genetic Tools for
Francisella Tularensis |
315,000 |
Reichman,Richard |
Training Program in Viral Diseases,
Vaccines/Biodefense |
2,101,663 |
Robert,Jacques |
Role of Non-Classical MHC Class
I and HSPs in Immunity |
1,173,900 |
Sant, Andrea |
Immunodominance in CD4 T Cell
Responses |
1,723,875 |
Sant, Andrea |
Selective Presentation of Autoantigens
by B Cells |
470,430 |
Santos, Kathlyn Santos |
Phage Vectors for HIV Vaccine
Development |
162,832 |
Szilagyi,Peter G |
Enhanced Surveillance for Newly
Vaccine-Preventable Disease |
3,203,164 |
Szilagyi,Peter G |
Rochester Center for Adolescent
Immunization Research (RCAIR) |
741,000 |
Szilagyi,Peter G |
Enhanced Surveillance-Newly Vaccine
Preventable Diseases |
2,477,555 |
Takimoto, Toru |
Host Range and Pathogenesis of
Paramyxoviruses |
1,102,500 |
Topham, David J |
Pivotal Role of VLA-1 in DC8 T
Cell Retention and Survival |
1,600,000 |
Treanor,John Jay |
Evaluation of Control Measures
Against Diseases Other Than AIDS |
13,954,252 |
Walsh,Edward E |
Pathogenesis of RSV Disease in
the Elderly |
2,584,052 |
Ward, Brian M |
Protein Interactions Involved
in Poxvirus Envelopment |
267,538 |
Zeng, Mingtao |
Genetic Immunization Against Pneumoccoccal
Disease |
661,315 |
Zeng, Mingtao |
New Genetic Vaccine to protect
Against Botulism |
630,000 |
Zheng, Wei-Ping |
Mapping of Transcription Network
in Th2 Cells |
472,500 |
|